Can you provide the last earnings date for SCHOTT PHARMA AG& CO KGAA?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) last reported earnings on 2/11/2026.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Earnings History & Surprises
FRA:1SXP • DE000A3ENQ51
Current stock price
13.92 EUR
+0.24 (+1.75%)
Last:
1SXP.DE Earnings overview
Past quarterly earnings results for SCHOTT PHARMA AG& CO KGAA (1SXP.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q2 / 2026
- EPS Estimate
- €0.24
- Revenue Estimate
- 255.07M
Last Reported
Most Recent- Release Date
- Feb 11, 2026
- Period
- Q1 / 2026
- EPS Reported
- €0.22
- EPS Surprise
- 14.88%
- Revenue Surprise
- 2.64%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 0.22 | 0.19 | 14.88% | 15.79% | 240.188M | 234.02M | 2.64% | 4.50% |
| Q4 2025 | 0.22 | 0.23 | -3.50% | - | 247.583M | 252.62M | -1.99% | 4.44% |
| Q3 2025 | 0.30 | 0.30 | -1.05% | -3.23% | 256.46M | 262.43M | -2.27% | 1.13% |
| Q2 2025 | 0.26 | 0.25 | 5.48% | 52.94% | 252.326M | 247.99M | 1.75% | 7.95% |
| Q1 2025 | 0.19 | 0.22 | -14.42% | -34.48% | 229.841M | 242.74M | -5.31% | -1.04% |
| Q4 2024 | 0.22 | 0.25 | -10.99% | -4.35% | 237.051M | 244.39M | -3.00% | 3.73% |
| Q3 2024 | 0.31 | 0.21 | 50.83% | - | 253.587M | 228.25M | 11.10% | -62.16% |
| Q2 2024 | 0.17 | 0.21 | -20.63% | - | 233.749M | 238.89M | -2.15% | - |
| Q1 2024 | 0.29 | 0.28 | 3.11% | - | 232.251M | 212M | 9.55% | - |
| Q4 2023 | 0.23 | 0.16 | 40.93% | - | 228.516M | 233.12M | -1.97% | 12.57% |
| Q3 2023 | - | - | 670.086M | - | 8.41% | |||
| Q4 2022 | - | - | 203M | - | - | |||
| Q3 2022 | - | - | 618.108M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
3.95%
Max EPS beat (4)
14.88%
Min EPS beat (4)
-3.50%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
0.03%
Max Revenue beat (4)
2.64%
Min Revenue beat (4)
-2.27%
Analysis
In the last 4 quarters, 1SXP.DE has beaten EPS estimates in 2 out of 4 releases
1SXP.DE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, 1SXP.DE has beaten the EPS estimates by 4.0% on average.
In the last 4 quarters, 1SXP.DE has beaten the revenue estimates by 0.0% on average.
Related analysis
SCHOTT PHARMA AG& CO KGAA / 1SXP.DE Earnings FAQ
Did 1SXP stock beat earnings estimates in the most recent quarter?
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often SCHOTT PHARMA AG& CO KGAA beats earnings estimates?
In the last 4 quarters, SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has beaten EPS estimates in 2 out of 4 releases.